CommercialCoverageMedium impact
11.00.06v, Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring
Independence Blue Cross·Sleep Medicine, Pulmonology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Oct 29, 2025
We identified it
Jun 19, 2026
Summary
Policy 11.00.06v for Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring has been reissued for commercial plans. This is a policy reissuance rather than new content changes, but billing teams should verify current coverage criteria and authorization requirements are up to date.
Action Required
By October 29, 2025: Billing team should review the complete policy at the source URL to verify current OSA treatment coverage criteria, prior authorization requirements, and billing guidelines are correctly configured in billing systems. Update any workflows for sleep study and OSA treatment billing to ensure compliance with reissued policy terms.